Simon Matoori1,2, Johannes M Froehlich2,3,4, Stefan Breitenstein5, Aleksis Doert4, Viktoria Pozdniakova6, Dow-Mu Koh7, Andreas Gutzeit8,9,10. 1. Department of Radiology, Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020, Salzburg, Austria. 2. Clinical Research Group, Hirslanden Clinic St. Anna, St.Anna-Strasse 32, 6006, Lucerne, Switzerland. 3. Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, Vladimir-Prelog-Weg 1-5 / 10, 8093, Zurich, Switzerland. 4. Department of Radiology, Cantonal Hospital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland. 5. Department of Surgery, Clinic for Visceral and Thoracic Surgery, Cantonal Hospital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland. 6. Department of Radiology, Stavanger University Hospital, Armauer Hansens vei 20, 4011, Stavanger, Norway. 7. Department of Radiology, Royal Marsden Hospital, Downs Road, Sutton, SM2 5PT, Surrey, England, UK. 8. Department of Radiology, Paracelsus Medical University Salzburg, Muellner Hauptstraße 48, 5020, Salzburg, Austria. agutzeit2000@gmail.com. 9. Clinical Research Group, Hirslanden Clinic St. Anna, St.Anna-Strasse 32, 6006, Lucerne, Switzerland. agutzeit2000@gmail.com. 10. Department of Radiology, Cantonal Hospital Winterthur, Brauerstrasse 15, 8401, Winterthur, Switzerland. agutzeit2000@gmail.com.
Abstract
OBJECTIVES: To identify correlations of signal enhancements (SE) and SE normalized to reference tissues of the spleen, kidney, liver, musculus erector spinae (MES) and ductus hepatocholedochus (DHC) on hepatobiliary phase gadoxetate-enhanced MRI with patient age in non-cirrhotic patients. METHODS: A heterogeneous cohort of 131 patients with different clinical backgrounds underwent a standardized 3.0-T gadoxetate-enhanced liver MRI between November 2008 and June 2013. After exclusion of cirrhotic patients, a cohort of 75 patients with no diagnosed diffuse liver disease was selected. The ratio of signal intensity 20 min post- to pre-contrast administration (SE) in the spleen, kidney, liver, MES and DHC, and the SE of the kidney, liver and DHC normalized to the reference tissues spleen or MES were compared to patient age. RESULTS: Patient age was inversely correlated with the liver SE normalized to the spleen and MES SE (both p < 0.001) and proportionally with the SE of the spleen (p = 0.043), the MES (p = 0.030) and the kidney (p = 0.022). No significant correlations were observed for the DHC (p = 0.347) and liver SE (p = 0.606). CONCLUSION: The age dependence of hepatic SE normalized to the enhancement in the spleen and MES calls for a cautious interpretation of these quantification methods. KEY POINTS: • Patient age was inversely correlated with spleen- and MES-corrected liver rSE (p < 0.001). • Patient age was correlated with spleen (p = 0.043) and MES SE (p = 0.030). • Patient age may confound quantitative liver function assessment using gadoxetate-enhanced liver MRI.
OBJECTIVES: To identify correlations of signal enhancements (SE) and SE normalized to reference tissues of the spleen, kidney, liver, musculus erector spinae (MES) and ductus hepatocholedochus (DHC) on hepatobiliary phase gadoxetate-enhanced MRI with patient age in non-cirrhotic patients. METHODS: A heterogeneous cohort of 131 patients with different clinical backgrounds underwent a standardized 3.0-T gadoxetate-enhanced liver MRI between November 2008 and June 2013. After exclusion of cirrhotic patients, a cohort of 75 patients with no diagnosed diffuse liver disease was selected. The ratio of signal intensity 20 min post- to pre-contrast administration (SE) in the spleen, kidney, liver, MES and DHC, and the SE of the kidney, liver and DHC normalized to the reference tissues spleen or MES were compared to patient age. RESULTS:Patient age was inversely correlated with the liver SE normalized to the spleen and MES SE (both p < 0.001) and proportionally with the SE of the spleen (p = 0.043), the MES (p = 0.030) and the kidney (p = 0.022). No significant correlations were observed for the DHC (p = 0.347) and liver SE (p = 0.606). CONCLUSION: The age dependence of hepatic SE normalized to the enhancement in the spleen and MES calls for a cautious interpretation of these quantification methods. KEY POINTS: • Patient age was inversely correlated with spleen- and MES-corrected liver rSE (p < 0.001). • Patient age was correlated with spleen (p = 0.043) and MES SE (p = 0.030). • Patient age may confound quantitative liver function assessment using gadoxetate-enhanced liver MRI.
Authors: Andreas Geier; Suk Kyum Kim; Thomas Gerloff; Christoph G Dietrich; Frank Lammert; Saul J Karpen; Bruno Stieger; Peter J Meier; Siegfried Matern; Carsten Gartung Journal: J Hepatol Date: 2002-08 Impact factor: 25.083
Authors: Andreas Geier; Christoph G Dietrich; Sebastian Voigt; Suk-Kyum Kim; Thomas Gerloff; Gerd A Kullak-Ublick; Johann Lorenzen; Siegfried Matern; Carsten Gartung Journal: Hepatology Date: 2003-08 Impact factor: 17.425
Authors: Guido M Kukuk; Stephanie G Schaefer; Rolf Fimmers; Dariusch R Hadizadeh; Samer Ezziddin; Ulrich Spengler; Hans H Schild; Winfried A Willinek Journal: Eur Radiol Date: 2014-07-17 Impact factor: 5.315
Authors: Miriam G Mooij; Ute I Schwarz; Barbara A E de Koning; J Steven Leeder; Roger Gaedigk; Janneke N Samsom; Edwin Spaans; Johannes B van Goudoever; Dick Tibboel; Richard B Kim; Saskia N de Wildt Journal: Drug Metab Dispos Date: 2014-05-14 Impact factor: 3.922
Authors: Simon Matoori; Bharti Khurana; Marta Chadwick Balcom; Johannes M Froehlich; Sonja Janssen; Rosemarie Forstner; Ann D King; Dow-Mu Koh; Andreas Gutzeit Journal: Eur Radiol Date: 2020-10-06 Impact factor: 7.034